Company registration number 10132379 (England and Wales)
HEYNUTRITION LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2023
HEYNUTRITION LTD
COMPANY INFORMATION
Director
Mr Carlos Ordonez Gil
Company number
10132379
Registered office
International House
10 Churchill Way
Cardiff
Wales
CF10 2HE
Auditor
Moore NHC Audit Limited
East Wing
Goffs Oak House
Goffs Lane
Goffs Oak
Hertfordshire
EN7 5GE
Accountant
Ecommerce Accountants LLP
Unit 402, 37 Cremer Street
Brickfields
London
E2 8HD
HEYNUTRITION LTD
CONTENTS
Page
Strategic report
1 - 2
Director's report
3 - 4
Independent auditor's report
5 - 6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 20
HEYNUTRITION LTD
STRATEGIC REPORT
FOR THE YEAR ENDED 30 DECEMBER 2023
- 1 -

The director presents the strategic report for the year ended 30 December 2023.

Principal activities

Heynutrition Limited's principal activity continues to be the production and distribution of high-quality nutritional supplements. The company focuses on delivering health products tailored to specific health needs and consumer preferences. In 2023, Hey Nutrition continued to operate as a direct-to-consumer (D2C) business in the UK, primarily through its Shopify and Amazon channels.

Review of the business

Heynutrition Limited remains dedicated to improving individual health and well-being by offering premium-quality supplements that meet modern consumer health goals.

The company achieved a turnover of £12.47 million in 2023, an increase of £1.70 million (15.8%) compared with the previous year’s revenue of £10.77 million. This growth was driven by a strong performance in both Shopify and Amazon channels, with Shopify contributing £10.80 million and Amazon £1.65 million.

Gross profit increased to £9.28 million (2022: £9.02 million), resulting in a gross margin of 74.4%, compared to 83.8% in 2022. The reduction in margin was primarily due to increased product and shipping costs and higher marketing investment to sustain customer acquisition and brand expansion.

Administrative expenses rose to £5.44 million (2022: £3.93 million), driven mainly by additional marketing expenditure totaling £4.50 million, alongside general operational scaling.

Overall, the company’s performance in 2023 remained in line with the directors’ expectations. The business maintained steady growth through brand awareness and retention initiatives, supported by an expanded Amazon presence and improved logistics efficiency.

Principal risks and uncertainties

The principal risks faced by Heynutrition Limited include inflationary pressures on raw materials and packaging, as well as volatility in digital advertising costs. Additional risks include potential changes in health supplement regulations and disruptions in supply chain operations.

 

The company continues to mitigate these risks through proactive supplier diversification, effective pricing management, and close monitoring of compliance requirements across its operating regions.

Development and performance

The company plans to continue expanding its product portfolio and investing in the development of new health supplement formulations in 2024. Efforts will also focus on:

These initiatives are designed to maintain growth momentum, improve profitability, and reinforce Heynutrition Limited's market leadership in the UK health supplements category.

HEYNUTRITION LTD
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
- 2 -
Key performance indicators

Sales Growth: +15.8% year-over-year (2023 vs. 2022)

Gross Profit Margin: 74.44% (2022: 83.8%)

Return on Ad Spend (ROAS): 2.5x overall average

Customer Lifetime Value (LTV): £88.04 per customer

Customer Satisfaction: Average rating of 4.3/5 on Shopify, with over 3,400 Trustpilot reviews rated “Excellent.”

On behalf of the board

Mr Carlos Ordonez Gil
Director
1 December 2025
HEYNUTRITION LTD
DIRECTOR'S REPORT
FOR THE YEAR ENDED 30 DECEMBER 2023
- 3 -

The director presents his annual report and financial statements for the year ended 30 December 2023.

Results and dividends

The results for the year are set out on page 7.

No ordinary dividends were paid. The director does not recommend payment of a final dividend.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mr Carlos Ordonez Gil
Mr Lawrence Fairbank Yates
(Resigned 6 January 2025)
Auditor

In accordance with the company's articles, a resolution proposing that Moore NHC Audit Limited be reappointed as auditor of the company will be put at a General Meeting.

Statement of director's responsibilities

The director is responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

HEYNUTRITION LTD
DIRECTOR'S REPORT (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
- 4 -
On behalf of the board
Mr Carlos Ordonez Gil
Director
1 December 2025
HEYNUTRITION LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HEYNUTRITION LTD
- 5 -

Disclaimer of opinion on financial statements

We were engaged to audit the financial statements of Heynutrition Ltd (the 'company') for the year ended 30 December 2023 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

We do not express an opinion on the financial statements of the company. Because of the significance of the matter described in the Basis for disclaimer of opinion section of our report, we have not been able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on the financial statements.

Basis for disclaimer of opinion

We were unable to attend the counting of physical inventories at the beginning and end of the year. We were unable to satisfy ourselves by alternative means concerning the inventory quantities held as at 30 December 2023 and 2022 which are stated on the balance sheet at £1,013,845 and £1,456,348. Respectively. Additionally, we were not able to gain assurance around the unit values of the stock items.

 

In addition, we were not provided with sufficient, appropriate audit evidence for a significant proportion of the testing we performed in the year ended 30 December 2023 and also in the year ended 30 December 2022.

 

As the balances we have been unable to satisfactorily test are material to the financial statements, we are required to issue a disclaimer of opinion. A disclaimer of opinion was also issued in the year ended 30 December 2022. As of the date of the report management are in the process of rectifying the system deficiencies which existed throughout the year ended 30 December 2023.

 

Opinions on other matters prescribed by the Companies Act 2006

Because of the significance of the matter described in the basis for disclaimer of opinion section of our report, we have been unable to form an opinion, whether based on the work undertaken in the course of the audit:

 

 

Matters on which we are required to report by exception

Notwithstanding our disclaimer of an opinion on the financial statements, in the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, performed subject to the pervasive limitation described above, we have not identified material misstatements in the strategic report or the directors’ report.

 

Arising from the limitation of our work referred to above:

 

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report if, in our opinion:

 

HEYNUTRITION LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HEYNUTRITION LTD (CONTINUED)
- 6 -
Responsibilities of director

As explained more fully in the director's responsibilities statement, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our responsibility is to conduct an audit in accordance with International Standards on Auditing (UK) (ISAs(UK)) and applicable law.

 

However, because of the matter described in the Basis for disclaimer of opinion section, we were not able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on the financial statements.

 

We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Daniel Garfield (Senior Statutory Auditor)
For and on behalf of Moore NHC Audit Limited, Statutory Auditor
Chartered Accountants
East Wing
Goffs Oak House
Goffs Lane
Goffs Oak
Hertfordshire
EN7 5GE
2 December 2025
HEYNUTRITION LTD
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 30 DECEMBER 2023
- 7 -
2023
2022
Notes
£
£
Turnover
3
12,470,032
10,764,470
Cost of sales
(3,191,540)
(1,742,213)
Gross profit
9,278,492
9,022,257
Administrative expenses
(5,449,802)
(3,933,453)
Operating profit
4
3,828,690
5,088,804
Interest receivable and similar income
7
4,302
3,957
Interest payable and similar expenses
8
(41,590)
(6,101)
Profit before taxation
3,791,402
5,086,660
Tax on profit
9
(887,239)
(935,343)
Profit for the financial year
2,904,163
4,151,317

The profit and loss account has been prepared on the basis that all operations are continuing operations.

HEYNUTRITION LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 DECEMBER 2023
- 8 -
2023
2022
£
£
Profit for the year
2,904,163
4,151,317
Other comprehensive income
-
-
Total comprehensive income for the year
2,904,163
4,151,317
HEYNUTRITION LTD
BALANCE SHEET
AS AT
30 DECEMBER 2023
30 December 2023
- 9 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
10
816
1,785
Current assets
Stocks
12
1,013,845
1,456,348
Debtors
13
11,421,205
7,867,073
Cash at bank and in hand
1,280,485
895,688
13,715,535
10,219,109
Creditors: amounts falling due within one year
14
(2,768,758)
(2,177,280)
Net current assets
10,946,777
8,041,829
Total assets less current liabilities
10,947,593
8,043,614
Provisions for liabilities
Deferred tax liability
15
155
339
(155)
(339)
Net assets
10,947,438
8,043,275
Capital and reserves
Called up share capital
16
10
10
Profit and loss reserves
10,947,428
8,043,265
Total equity
10,947,438
8,043,275

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 1 December 2025 and are signed on its behalf by:
Mr Carlos Ordonez Gil
Director
Company registration number 10132379 (England and Wales)
HEYNUTRITION LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 DECEMBER 2023
- 10 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2022
10
3,891,948
3,891,958
Year ended 30 December 2022:
Profit and total comprehensive income
-
4,151,317
4,151,317
Balance at 30 December 2022
10
8,043,265
8,043,275
Year ended 30 December 2023:
Profit and total comprehensive income
-
2,904,163
2,904,163
Balance at 30 December 2023
10
10,947,428
10,947,438
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2023
- 11 -
1
Accounting policies
Company information

Heynutrition Ltd is a private company limited by shares incorporated in England and Wales. The registered office is International House, 10 Churchill Way, Cardiff, Wales, CF10 2HE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of WGUK Operations Limited. These consolidated financial statements are available from its registered office, 10 Churchill Way, Cardiff, Wales, CF10 2HE.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
Straight line basis over four years
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
1
Accounting policies
(Continued)
- 12 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
1
Accounting policies
(Continued)
- 13 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
1
Accounting policies
(Continued)
- 14 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
1
Accounting policies
(Continued)
- 15 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

In the director's opinion there are no significant judgements or key sources of estimation uncertainty.

3
Turnover and other revenue

Turnover, all of which originates in the United Kingdom, comprises retail and wholesale sales, net of returns, and is shown exclusive of value added tax and discounts allowed.

HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
3
Turnover and other revenue
(Continued)
- 16 -
2023
2022
£
£
Turnover analysed by geographical market
United Kingdom
12,470,032
10,764,470
2023
2022
£
£
Other revenue
Interest income
4,302
3,957
4
Operating profit
2023
2022
Operating profit for the year is stated after charging:
£
£
Exchange losses
19,990
2,752
Fees payable to the company's auditor for the audit of the company's financial statements
35,000
25,000
Depreciation of owned tangible fixed assets
969
969
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Management
2
2

Their aggregate remuneration comprised:

2023
2022
£
£
Wages and salaries
-
0
300,000
6
Director's remuneration
2023
2022
£
£
Remuneration for qualifying services
-
0
300,000
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
6
Director's remuneration
(Continued)
- 17 -
Remuneration disclosed above include the following amounts paid to the highest paid director:
2023
2022
£
£
Remuneration for qualifying services
-
300,000
7
Interest receivable and similar income
2023
2022
£
£
Interest income
Other interest income
4,302
3,957
8
Interest payable and similar expenses
2023
2022
£
£
Other interest
41,590
6,101
9
Taxation
2023
2022
£
£
Current tax
UK corporation tax on profits for the current period
887,423
935,527
Deferred tax
Origination and reversal of timing differences
(184)
(184)
Total tax charge
887,239
935,343
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
9
Taxation
(Continued)
- 18 -

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2023
2022
£
£
Profit before taxation
3,791,402
5,086,660
Expected tax charge based on the standard rate of corporation tax in the UK of 23.40% (2022: 19.00%)
887,188
966,465
Tax effect of expenses that are not deductible in determining taxable profit
235
14,474
Group relief
-
0
(45,412)
Short term timing differences
(184)
(184)
Taxation charge for the year
887,239
935,343
10
Tangible fixed assets
Computers
£
Cost
At 1 January 2023 and 30 December 2023
3,875
Depreciation and impairment
At 1 January 2023
2,090
Depreciation charged in the year
969
At 30 December 2023
3,059
Carrying amount
At 30 December 2023
816
At 30 December 2022
1,785
11
Fixed asset investments
2023
2022
£
£
Other investments
-
0
-
0
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
11
Fixed asset investments
(Continued)
- 19 -
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 January 2023 & 30 December 2023
12,631
Impairment
At 1 January 2023 & 30 December 2023
12,631
Carrying amount
At 30 December 2023
-
At 30 December 2022
-
12
Stocks
2023
2022
£
£
Finished goods and goods for resale
1,013,845
1,456,348
13
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
20
-
0
Amounts owed by group undertakings
11,043,826
7,753,197
Other debtors
377,359
113,876
11,421,205
7,867,073
14
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
94,862
518,747
Amounts owed to group undertakings
928,416
261,759
Corporation tax
929,251
941,828
Other taxation and social security
550,216
184,144
Other creditors
205,955
270,398
Accruals and deferred income
60,058
404
2,768,758
2,177,280
HEYNUTRITION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2023
- 20 -
15
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2023
2022
Balances:
£
£
Other
155
339
2023
Movements in the year:
£
Liability at 1 January 2023
339
Credit to profit or loss
(184)
Liability at 30 December 2023
155
16
Share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
10
10
10
10
17
Related party transactions
Other information

The company has taken the exemption available under Financial Reporting Standard 102 not to disclose related party transactions with wholly owned subsidiaries within the group.

18
Ultimate controlling party

The company's immediate parent undertaking is WGUK Operations Ltd.

 

The ultimate parent undertaking is Wholesome Goods, Inc (incorporated in Florida). Its registered office is 5355 115th Ave N, Clearwater, Florida, 33760.

 

The company's ultimate controlling party is by virtue of their interest in the share capital of the company.

2023-12-302023-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300Mr Carlos Ordonez GilMr Lawrence Fairbank Yates101323792023-01-012023-12-3010132379bus:Director12023-01-012023-12-3010132379bus:Director22023-01-012023-12-3010132379bus:RegisteredOffice2023-01-012023-12-3010132379bus:Agent12023-01-012023-12-30101323792023-12-30101323792022-01-012022-12-3010132379core:RetainedEarningsAccumulatedLosses2022-01-012022-12-3010132379core:RetainedEarningsAccumulatedLosses2023-01-012023-12-30101323792022-12-3010132379core:ComputerEquipment2023-12-3010132379core:ComputerEquipment2022-12-3010132379core:WithinOneYear2023-12-3010132379core:WithinOneYear2022-12-3010132379core:CurrentFinancialInstruments2023-12-3010132379core:CurrentFinancialInstruments2022-12-3010132379core:ShareCapital2023-12-3010132379core:ShareCapital2022-12-3010132379core:RetainedEarningsAccumulatedLosses2023-12-3010132379core:RetainedEarningsAccumulatedLosses2022-12-3010132379core:ShareCapital2021-12-3110132379core:RetainedEarningsAccumulatedLosses2021-12-3110132379core:ShareCapitalOrdinaryShareClass12023-12-3010132379core:ShareCapitalOrdinaryShareClass12022-12-3010132379core:ComputerEquipment2023-01-012023-12-301013237912023-01-012023-12-301013237912022-01-012022-12-3010132379core:UKTax2023-01-012023-12-3010132379core:UKTax2022-01-012022-12-3010132379core:ComputerEquipment2022-12-3110132379core:Non-currentFinancialInstruments2023-12-3010132379core:Non-currentFinancialInstruments2022-12-3010132379bus:OrdinaryShareClass12023-01-012023-12-3010132379bus:OrdinaryShareClass12023-12-3010132379bus:OrdinaryShareClass12022-12-3010132379bus:PrivateLimitedCompanyLtd2023-01-012023-12-3010132379bus:FRS1022023-01-012023-12-3010132379bus:Audited2023-01-012023-12-3010132379bus:FullAccounts2023-01-012023-12-30xbrli:purexbrli:sharesiso4217:GBP